Pediatrix Medical Group (FRA:PDC) Tariff Resilience Score: 9/10 (As of Jul. 01, 2026)


FRA:PDC Pediatrix Medical Group Inc FRA:PDC
58 GF Score
Price €21.60
GF Value €11.21
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Pediatrix Medical Group Tariff Resilience Score?

Pediatrix Medical Group FRA:PDC 58 Tariff Resilience Score is 9 as of Jul. 01, 2026. GuruFocus rates FRA:PDC with a GF Score™ of 58/100 and a GF Value™ of €11.21 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 675 Healthcare Providers & Services companies, Pediatrix Medical Group ranks better than 99.85% on this metric.

Pediatrix Medical Group has the Tariff Resilience Score of 9, which implies that the company might have Highly Resilient.

Pediatrix Medical Group has Healthcare services with negligible international trade exposure. Revenue is primarily domestic, minimizing tariff impact.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Pediatrix Medical Group might have Highly Resilient.

Pediatrix Medical Group  (FRA:PDC) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Pediatrix Medical Group Tariff Resilience Score Related Terms

FRA:PDC vs SEM, AGL, SGRY: Tariff Resilience Score Comparison

For the Medical Care Facilities subindustry, Pediatrix Medical Group's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pediatrix Medical Group Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Pediatrix Medical Group's Tariff Resilience Score falls into.


FRA:PDC
58GF Score
Pediatrix Medical Group Inc FRA:PDC
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 9 mean?
Pediatrix Medical Group (FRA:PDC) has a Tariff Resilience Score of 9 as of Jul. 01, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Pediatrix Medical Group ranks #1 out of 675 companies in the Healthcare Providers & Services industry, placing it in the top 0.099999999999994%.
Is Pediatrix Medical Group's Tariff Resilience Score too high?
Pediatrix Medical Group's current Tariff Resilience Score is 9. Based on the distribution chart, Pediatrix Medical Group ranks #1 out of 675 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pediatrix Medical Group has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's Tariff Resilience Score compare to SEM and AGL?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #1 out of 675 companies for Tariff Resilience Score. This places Pediatrix Medical Group in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Pediatrix Medical Group's current Tariff Resilience Score is 9. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Pediatrix Medical Group (FRA:PDC) is currently considered Significantly Overvalued. The stock's GF Value™ is €11.21, compared to a current price of €21.60 — trading 92.7% above its estimated fair value. The current Tariff Resilience Score is 9. Pediatrix Medical Group's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current Tariff Resilience Score is 9 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?

Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued. The current stock price of €21.60 is trading 92.7% above its estimated GF Value™ of €11.21. GuruFocus considers Pediatrix Medical Group to be Significantly Overvalued.

Key valuation signals for FRA:PDC:

  • Tariff Resilience Score: 9
  • GF Value™: €11.21 vs. price of €21.60 (92.7% above fair value)
  • GF Score™: 58/100 with 8 warning signs

No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pediatrix Medical Group Business Description

Other Exchanges MD:USA
Address 1301 Concord Terrace, Sunrise, FL, USA, 33323
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
58GF Score

Get the complete analysis for FRA:PDC

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.60
Price
€11.21
GF Value